Online weight loss treatment in New Hampshire
Surfbound connects eligible adults in New Hampshire with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in New Hampshire?
Yes. Eligible adults across New Hampshire can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in New Hampshire reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your New Hampshire address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Granite State · Northeast region. A small state with limited in-person obesity-medicine options. Quick statewide online access.
Coverage across New Hampshire
Surfbound lists 2 New Hampshire cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to New Hampshire
Every New Hampshire order is filled by a licensed compounding pharmacy and dispatched after the provider signs off. Addresses across the Northeast region, from Manchester, Nashua, Concord to smaller communities see different transit times depending on distance and weekends, and tracking is emailed on dispatch.
What's included in every New Hampshire plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
New Hampshire coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in New Hampshire. The New Hampshire provider access & process page covers the clinical steps in detail.
Surfbound lists 2 New Hampshire cities with a dedicated local page. Because care is delivered online, you can start from anywhere in New Hampshire — the city list is a navigation aid, not a limit on where you can begin.
The New Hampshire telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in New Hampshire. You complete a health intake online, and a licensed provider credentialed in New Hampshire reviews your information remotely.
New Hampshire permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in New Hampshire may review a New Hampshire patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in New Hampshire” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active New Hampshire license issued by the New Hampshire Board of Medicine, and any pharmacy filling your prescription must be licensed in New Hampshire. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in New Hampshire” section on this page.
Across New Hampshire, semaglutide runs $169/mo and tirzepatide $219/mo — one flat rate that covers the New Hampshire-licensed provider review. There is no membership fee, and the total appears before checkout.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
No — in New Hampshire, medication is dispensed only when the reviewing provider finds treatment medically appropriate.
Yes — New Hampshire residents can transfer an existing GLP-1 plan. Note your medication and dose in the intake, and the reviewing New Hampshire provider determines the prescription after assessing whether a dose match is appropriate.
The GLP-1 total-cost calculator compares equal monthly recurring cost — membership, shipping and dose surcharges for any plan — against Surfbound's flat New Hampshire rate, so New Hampshire residents compare complete costs rather than a headline number.
Compounded semaglutide is one of the two GLP-1 options available across New Hampshire, priced flat each month with the provider review included. Nothing ships unless a New Hampshire-licensed provider approves treatment. It is not an FDA-approved medication.
Tirzepatide is available to New Hampshire residents and reviewed the same way as semaglutide. The provider review is included in the monthly price, and treatment is dispensed only when a New Hampshire-licensed provider finds it appropriate. Compounded tirzepatide is not FDA-approved.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and New Hampshire residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the New Hampshire-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in New Hampshire. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed New Hampshire provider approves your medication. A small state with limited in-person obesity-medicine options.
Yes. New Hampshire residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed New Hampshire provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across New Hampshire with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A New Hampshire-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. New Hampshire residents complete a short online intake on their own schedule, and a New Hampshire-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. A small state with limited in-person obesity-medicine options. Quick statewide online access.
Yes. Men across New Hampshire begin with a private online intake, a licensed New Hampshire provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches New Hampshire residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in New Hampshire
What governs a provider treating a New Hampshire patient online, and where you can check it yourself.
State medical board
New Hampshire Board of MedicineNew Hampshire Board of Medicine licenses the providers who review New Hampshire intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
New Hampshire Revised Statutes Annotated Chapter 329Opens the official New Hampshire code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active New Hampshire license to evaluate or treat a patient who is physically located in New Hampshire. Every New Hampshire intake is routed to a provider credentialed in New Hampshire, and a prescription is issued only when that provider determines treatment is medically appropriate.
New Hampshire permits telemedicine prescribing when a proper provider-patient relationship has been established through an adequate medical evaluation, which Surfbound’s intake and review process provides.
Surfbound is an online service. We do not have physical offices in New Hampshire. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in New Hampshire and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official New Hampshire state government agency. Provider licensure in New Hampshire is governed by the New Hampshire Board of Medicine.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.